Soul Patts (ASX:SOL) Delivers 9.9% Growth in Cashflow, Increases Interim Dividend by 10%
Soul Patts (ASX:SOL) reports a 9.9% cash flow growth and a 10% increase in interim dividends for 1H25.
Brickworks Limited (ASX:BKW) Increases Interim Dividend and Reports Strong Earnings Growth
Brickworks Limited (ASX:BKW) announces an increased interim dividend and significant growth in underlying earnings for the first half of FY2025.
Golden Cross Resources (ASX:GCR) Completes Copper Hill Gravity Survey
Golden Cross Resources (ASX:GCR) completes a gravity survey at Copper Hill Tenement, enhancing exploration for copper-gold mineralisation.
Dreadnought Resources Ltd (ASX:DRE) Consolidates Further Gold Ground at Mangaroon
Dreadnought Resources (ASX:DRE) expands Mangaroon Gold Project by acquiring E09/2479, enhancing gold exploration prospects.
Strategic Energy Resources (ASX:SER) Secures Bulimba Gold Project
Strategic Energy Resources (ASX:SER) secures the Bulimba Gold Project in NE Queensland, targeting significant gold deposits.
Prospect Resources Limited (ASX:PSC) Identifies High-Priority Drill Target at Nyungu South
Prospect Resources (ASX:PSC) identifies a high-priority drill target at Nyungu South, enhancing exploration prospects at the Mumbezhi Copper Project.
Olympio Metals Limited (ASX:OLY) Identifies High Priority Target at Bousquet Gold Project
Olympio Metals Limited (ASX:OLY) identifies Paquin East as a high priority drilling target at its Bousquet Gold Project, aiming to expand mineralisation in Q3 2025.
Artemis Resources (ASX:ARV) Completes Phase One Drilling at Carlow Tenement
Artemis Resources (ASX:ARV) completes initial drilling phase at Carlow Tenement, testing high-priority gold targets with promising geological findings.
Qoria (ASX:QOR) Secures Strategic Partnership with Ohio Education Council
Qoria (ASX:QOR) secures a strategic partnership with Ohio Education Computer Network to enhance student safety and wellbeing services statewide.
Rhythm Biosciences Ltd (ASX:RHY) Records First Commercial Sales of geneType Products
Rhythm Biosciences (ASX:RHY) records its first commercial sales of geneType products, anticipating growth throughout the year.